Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Patent
1995-06-07
1998-12-08
Ulm, John
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
435 711, 435 712, 435 6952, 4351723, 4352523, 4353201, 935 11, 935 22, 935 66, 935 72, 530351, C12N 1524, C12N 510
Patent
active
058470980
ABSTRACT:
A homogeneous interleukin 1.beta. (IL-1.beta.), its derivative having a modified amino acid sequence of IL-1.beta., a gene coding for said derivative, medical composition comprising said derivative as a pharmaceutically effective component and a medicinal use of homogeneous IL-1.beta. and the derivative.
REFERENCES:
patent: 4518584 (1985-05-01), Mark et al.
patent: 4568640 (1986-02-01), Rubin
patent: 4762914 (1988-08-01), Auron et al.
patent: 4766069 (1988-08-01), Auron et al.
patent: 4959314 (1990-09-01), Mark et al.
Zoller et al, Nucleic Acid Res., 10(20):6487-6500 (1982).
Clark et al, Nucleic Acid Res., 14920):7897-7914 (1986).
Tsuji et al, Biochem., 26:3129-3134 (1987).
Wang et al, Science, 224:1431-1443 (1984).
Wells et al, Gene, 34:315-323 (1985).
Suhamanian, Bio/Technol, 3:597 (1985).
Von Heijne, Eur. J. Biochem., 133:17-21 (1983).
Perlman et al, J. Mol. Biol., 167:391-409 (1983).
Inouge et al, Protein Engineering, Ed., pp 157-171 (1986).
Robinson et al, introduction to Proteins and Protein Engineering, pp. 258-259 (1986).
Regenmortel, TIBS, 11:36-39 (1986).
Darrel et al, Nature, 283:433 (1980).
March et al, Nature, 315(6021):641-647 (1985).
Dinarello, Reviews of Infections Diseases, 691):51-95 (1984).
J. of Immunology, 122(5):2112-2118 (1979).
Federation Proceedings, 41(2):257-262 (1982).
Cellular Immunology, 80:223-229 (1983).
Nature, 309:56-59 (1984).
J. Exp. Med., 160:772-787 (1984).
Cellular Immunology, 48:433-436 (1979).
The New England Journal of Medicine, 311(22):1413 (1984).
Proc. Natl. Acad. Sci., U.S.A., 81:7907-7911 (1984).
Nucleic Acid Res., 13(16)L5869-5882 (1985).
Nature, 304:449-451 (1983).
Cellular Immunology, 63:164-176 (1981).
J. Exp. Med., 150:709-714 (1979).
J. of Immunology, 130(6):2708-2714 (1983).
J. of Immunology, 132(3):1311-1316 (1984).
Nature, 314:266-268 (1985).
Nature, 312:458-462 (1984).
Biochemical and Biophysical Research Communications, 14(1):285-291 (1986).
J. Exp. Med., 161:490-502 (1985).
J. Exp. Med., 164:237-250 (1986).
J. of Immunology, 135(6):3962-3968 (1985).
J. of Immunology, 136(7):2483-2485 (1986).
J. of Immunology, 136(7):2492-2497 (1986).
J. of Immunology, 136(9):3304-3310 (1986).
Immunology Today, 7(2):45-56 (1986).
Jpn. J. Cancer Res. (Gann), 77:767-773 (1986).
Proceedings of AACR, 26:269 and 1058 (1985).
The Physiologic, Metobolic, and Immunologic Actions of interleukin-1: (Proceedings of a Symposium Held in Ann Arbor, Michigan, Jun. 4-6, 1985), pp. 253-262, Alan R. Liss, Inc., New York.
Eur. J. Immunol., 14:898-901 (1984).
Bio/Technology, 4:1078-1082 (1986).
Clin. Exp. Immunol., 55:295-302 (1984).
Arthritis and Rheumatism, 26(8):975-983 (1983).
Arthritis and Rheumatism, 28(8):853-862 (1985).
Immunological Rev., 63:51-72 (1982).
J. of Immunol., 136(8):3098-3102 (1986).
J. Clin. Invest., 79:48-51 (1987).
6th International Congress of Immunology, Abstracts, Jul. 6-11, 1986, Toronto, Canada, pp. 343-346, 349, 350-354 (particularly Theme Nos. 3.31.14, 3.31.22, 3.31.43, 3.31.39, 3.31.40, 3.31.38 and 3.32.23).
Metabolism, 23, Extra Ed. "Immunology '86", pp. 97-104 (1986).
Biochemical and Biophysical Research Communications, 143(1):345-352 (1987).
Medical Immunology, 12(6):753-760 (1986).
Proc. Jap. Soc. Immunol., 16:167 and 173 (1986).
Biochemistry, 58(8):840 (1986).
Jpn. J. Clin. Immunol., 9(5):330-332 (1986).
J. Exp. Med., 162:790-801 (1985).
Wingfield et al, Eur. J. Biochem., 160:491-497 (1986).
Meyers, J. Biol. Chem., 262:11176-11181 (1987).
Narachi et al, J. Biol. Chem, 262:13107-13110 (1987).
Arakawa et al, Protein Engineering, 3:721-724 (1990).
Yamagishi et al, Protein Engineering, 3:713-719 (1990).
Perry et al, Science, 226:555-557 (1984).
Hirai Yoshikatsu
Hong Yeong-Man
Ishii Kiyoshi
Kaneta Mayumi
Kawai Kazuyoshi
Mertz Prema
Otsuka Pharmaceutcal Co., Ltd.
Ulm John
LandOfFree
DNA encoding interleukin IL-1.beta. mutant does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with DNA encoding interleukin IL-1.beta. mutant, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and DNA encoding interleukin IL-1.beta. mutant will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-178424